Clostridioides difficile spores (C. difficile spores)

Clostridioides difficile (formerly Clostridium difficile) spores are the dormant, metabolically inactive, and highly resistant forms of the C. difficile bacterium. These spores are characterized by a multi-layered proteinaceous coat that protects the bacterial genome from environmental stressors, including heat, radiation, and common alcohol-based disinfectants, allowing them to persist in healthcare environments for long periods. When ingested by a host with a disrupted gut microbiome, the spores sense specific germinants, such as primary bile acids, and transition into toxin-producing vegetative cells that cause Clostridioides difficile infection (CDI). In a clinical context, the spores are a primary target for preventing recurrent infection. While traditional antibiotics like vancomycin target the vegetative state, they do not kill the dormant spores, which often leads to relapse once treatment ends. Modern therapeutic strategies focus on inhibiting sporulation (e.g., fidaxomicin), neutralizing the toxins released during germination (e.g., bezlotoxumab), or restoring a healthy microbiome (e.g., fecal microbiota transplants or microbial consortia) to re-establish bile acid metabolism that naturally inhibits spore germination. Understanding the biology of these spores is critical for infection control and the development of next-generation therapies aimed at breaking the cycle of recurrence.

Other names

Clostridium difficile sporesC. diff sporesDormant Clostridioides difficileC. difficile endospores

Inhibition of sporulation, inhibition of germination through restoration of secondary bile acids, neutralization of toxins produced upon germination, or disruption of the vegetative cell wall following germination.